January 2002

|
Volume 14 Issue 1
Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent delivery failur…
The dream of any interventional cardiologist and of most stent companies is to have or find a “Panic stent”. A stent with such unique deliverability may need to compromise with other characteristics such as recoil, radial strength, plaque coverage, a…
Progression of congestive heart failure (CHF), although somewhat slowed by recent therapeutic developments, continues to be a growing problem among men and women age 50–80 years. It afflicts 2–4 million people in the United States and nearly 15 milli…
Case Description. A 45-year-old male with established coronary artery disease was admitted for 2 weeks of recurrent rest-onset chest pain symptoms. The patient had undergone 2 previous percutaneous coronary interventions at another hospital. In 1997,…
In this issue of the Journal of Invasive Cardiology, Mehta and colleagues provide an interesting report describing their initial clinical experience with a device, the X-Press system, for percutaneous closure of a femoral arterial access site. The de…
When percutaneous coronary intervention (PCI) was introduced, it was limited to patients suffering from refractory angina pectoris due to isolated lesions of a single major epicardial coronary artery.1 Over the last 2 decades, however, the treatment…
When percutaneous coronary intervention (PCI) was introduced, it was limited to patients suffering from refractory angina pectoris due to isolated lesions of a single major epicardial coronary artery.1 Over the last 2 decades, however, the treatment…
When percutaneous coronary intervention (PCI) was introduced, it was limited to patients suffering from refractory angina pectoris due to isolated lesions of a single major epicardial coronary artery.1 Over the last 2 decades, however, the treatment…
Direct percutaneous coronary angioplasty (d-PTCA) has emerged as an effective reperfusion strategy in patients presenting within the first 12 hours of an acute myocardial infarction as compared to intravenous thrombolytics.1–5 Several randomized thro…